why choose us

First received: November 27, 2022

Clinical Trial: Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: This Study is Conducted Under Inclusion/ Exclusion Criteria

Study Type: INTERVENTIONAL


Official Title: Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study

Brief Summary: Minimally Invasive Micro Sclerostomy (MIMS®) device is intended for the reduction of elevated Intraocular Pressure (IOP).MIMS® is a powered surgical device, designed to create a drainage channel of 100 microns diameter at the sclera-corneal junction and extending from the anterior chamber to the interface between the sclera and the conjunctiva (subconjunctival space), at the inferonasal quadrant of the eye (i.e., inferonasal sclerostomy).The drainage channel is created by a sterile surgical device made of…

Read more